Nga Ching Wo

738 total citations
28 papers, 616 citations indexed

About

Nga Ching Wo is a scholar working on Social Psychology, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Nga Ching Wo has authored 28 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Social Psychology, 13 papers in Molecular Biology and 8 papers in Endocrine and Autonomic Systems. Recurrent topics in Nga Ching Wo's work include Neuroendocrine regulation and behavior (27 papers), Receptor Mechanisms and Signaling (12 papers) and Electrolyte and hormonal disorders (7 papers). Nga Ching Wo is often cited by papers focused on Neuroendocrine regulation and behavior (27 papers), Receptor Mechanisms and Signaling (12 papers) and Electrolyte and hormonal disorders (7 papers). Nga Ching Wo collaborates with scholars based in United States, France and Switzerland. Nga Ching Wo's co-authors include Wood Yee Chan, M. Manning, Ling Cheng, Stoytcho Stoev, Maurice Manning, S. Stoev, Wieslaw A. Kliś, Aleksandra Olma, Marian Kruszynski and Wilbur H. Sawyer and has published in prestigious journals such as Nature, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Nga Ching Wo

28 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nga Ching Wo United States	16	522	229	224	148	107	28	616
Maurice Manning United States	12	475 0.9×	186 0.8×	280 1.3×	152 1.0×	135 1.3×	25	650
Jana Škopková Czechia	10	201 0.4×	81 0.4×	81 0.4×	57 0.4×	48 0.4×	31	310
Michael F. Johnson United States	12	173 0.3×	131 0.6×	184 0.8×	175 1.2×	8 0.1×	14	511
John Lowbridge United States	10	236 0.5×	78 0.3×	121 0.5×	80 0.5×	77 0.7×	16	331
M. ACOSTA United States	7	202 0.4×	61 0.3×	123 0.5×	60 0.4×	102 1.0×	9	319
Nicolas Deblon Switzerland	7	208 0.4×	281 1.2×	121 0.5×	30 0.2×	11 0.1×	7	558
Philippe Frétier France	10	78 0.1×	58 0.3×	133 0.6×	31 0.2×	9 0.1×	12	356
А. Г. Резніков Ukraine	11	128 0.2×	26 0.1×	66 0.3×	16 0.1×	19 0.2×	67	371
David R. Hole United Kingdom	13	111 0.2×	111 0.5×	87 0.4×	60 0.4×	18 0.2×	17	585
Barbara Chruścicka Poland	11	47 0.1×	88 0.4×	121 0.5×	86 0.6×	4 0.0×	18	334

Countries citing papers authored by Nga Ching Wo

Since Specialization

Citations

This map shows the geographic impact of Nga Ching Wo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nga Ching Wo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nga Ching Wo more than expected).

Fields of papers citing papers by Nga Ching Wo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nga Ching Wo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nga Ching Wo. The network helps show where Nga Ching Wo may publish in the future.

Co-authorship network of co-authors of Nga Ching Wo

This figure shows the co-authorship network connecting the top 25 collaborators of Nga Ching Wo. A scholar is included among the top collaborators of Nga Ching Wo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nga Ching Wo. Nga Ching Wo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stoev, Stoytcho, Ling Cheng, Maurice Manning, Nga Ching Wo, & Hazel H. Szeto. (2006). Design and synthesis of potent, highly selective vasopressin hypotensive agonists. Journal of Peptide Science. 12(9). 592–604. 5 indexed citations

Manning, Maurice, Ling Cheng, Stoytcho Stoev, et al.. (2005). Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. Journal of Peptide Science. 11(10). 593–608. 26 indexed citations

Guillon, Gilles, Ana Peña, Brigitte Murat, et al.. (2005). Position 4 analogues of [deamino-Cys1] arginine vasopressin exhibit striking species differences for human and rat V2/V1b receptor selectivity. Journal of Peptide Science. 12(3). 190–198. 10 indexed citations

Manning, Maurice, Stoytcho Stoev, Ling Cheng, Nga Ching Wo, & Wood Yee Chan. (2001). Design of Oxytocin Antagonists, which are more Selective than Atosiban. Journal of Peptide Science. 7(9). 449–465. 33 indexed citations

Chan, Wood Yee, Roberto Levi, Nga Ching Wo, et al.. (2001). Novel selective hypotensive vasopressin peptides: cardiovascular and structure–activity-relationship studies. European Journal of Pharmacology. 419(1). 65–72. 7 indexed citations

Chan, Wood Yee, Nga Ching Wo, Stoytcho Stoev, Ling Cheng, & Maurice Manning. (2000). Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays. Experimental Physiology. 85(s1). 7S–18S. 32 indexed citations

Manning, M., S. Stoev, Ling Cheng, Nga Ching Wo, & Wood Yee Chan. (1999). Discovery and Design of Novel Vasopresses Hypotensive Pepitide Agonists. Journal of Receptors and Signal Transduction. 19(1-4). 631–644. 8 indexed citations

Stoev, S., Ling Cheng, Aleksandra Olma, et al.. (1999). An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids. Journal of Peptide Science. 5(3). 141–153. 14 indexed citations

Chan, Wood Yee, Nga Ching Wo, Stoytcho Stoev, Ling Cheng, & Maurice Manning. (1998). Discovery of Novel Selective Hypotensive Vasopressin Peptides. Advances in experimental medicine and biology. 449. 451–453. 6 indexed citations

10.

Chan, Wood Yee, Nga Ching Wo, S. Stoev, Ling Cheng, & M. Manning. (1998). Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors. British Journal of Pharmacology. 125(4). 803–811. 15 indexed citations

11.

Manning, Maurice, Ling Cheng, Stoytcho Stoev, et al.. (1997). Position Three in Vasopressin Antagonist Tolerates Conformationally Restricted and Aromatic Amino Acid Substitutions: A Striking Contrast with Vasopressin Agonists. Journal of Peptide Science. 3(1). 31–46. 19 indexed citations

12.

Morin, Denis, Eve Mahé, Nathalie de la Cotte, et al.. (1997). Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors. European Journal of Pharmacology. 331(2-3). 285–293. 15 indexed citations

13.

Manning, Maurice, Ling Cheng, Wieslaw A. Kliś, et al.. (1995). Effects of a D-Cys6/L-Cys6 Interchange in Nonselective and Selective Vasopressin and Oxytocin Antagonists. Journal of Medicinal Chemistry. 38(10). 1762–1769. 8 indexed citations

14.

Manning, Maurice, Ling Cheng, Stoytcho Stoev, et al.. (1995). An exploration of the effects of L‐ and D‐tetrahydroisoquinoline‐3‐carboxylic acid substitutions at positions 2,3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin. Journal of Peptide Science. 1(1). 66–79. 15 indexed citations

15.

Manning, M., et al.. (1995). Design and synthesis of highly selectivein vitroandin vivouterine receptor antagonists of oxytocin: comparisons with Atosiban. International journal of peptide & protein research. 46(3-4). 244–252. 88 indexed citations

16.

Manning, Maurice, Stoytcho Stoev, Krzysztof Bańkowski, et al.. (1992). Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin. Journal of Medicinal Chemistry. 35(2). 382–388. 35 indexed citations

17.

Manning, Maurice, Zbigniew Grzonka, E Nawrocka, et al.. (1992). Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids. Journal of Medicinal Chemistry. 35(21). 3895–3904. 11 indexed citations

18.

Kruszynski, Marian, M. Manning, Nga Ching Wo, & W. H. Sawyer. (1990). Invertebrate neuropeptides resembling vasotocin and some analogues: Synthesis and pharmacological properties. Cellular and Molecular Life Sciences. 46(7). 771–773. 7 indexed citations

19.

Manning, Maurice, Stoytcho Stoev, ALEKSANDER KOLODZIEJCZYK, et al.. (1990). Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin. Journal of Medicinal Chemistry. 33(11). 3079–3086. 34 indexed citations

20.

Manning, M., Jacek Przybylski, Aleksandra Olma, et al.. (1987). No requirement of cyclic conformation of antagonists in binding to vasopressin receptors. Nature. 329(6142). 839–840. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact